Forest Wins Denial of Drug Lawsuit Class Certification

Drugmaker Forest Laboratories Inc. won a ruling that it doesn’t have to defend a group lawsuit claiming the company illegally marketed the antidepressants Celexa and Lexapro to patients under the age of 18.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.